Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8454049rdf:typepubmed:Citationlld:pubmed
pubmed-article:8454049lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:8454049lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:8454049lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:8454049lifeskim:mentionsumls-concept:C1157383lld:lifeskim
pubmed-article:8454049lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:8454049lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:8454049lifeskim:mentionsumls-concept:C0020923lld:lifeskim
pubmed-article:8454049pubmed:issue1-2lld:pubmed
pubmed-article:8454049pubmed:dateCreated1993-4-20lld:pubmed
pubmed-article:8454049pubmed:abstractTextThe imidazole antimycotics, miconazole, econazole and triclomazole as well as alpha-naphtoflavone, known as powerful inhibitors of cytochrome P450 and previously recognized as K+ channel blockers are shown to be potent activators of the base exchange enzyme system responsible for the biosynthesis of phosphatidylserine in Jurkat T cells. The inhibition of CD3-induced Ca2+ influx by antimycotics but not by K+ channel blockers, demonstrated that the rise in phosphatidylserine synthesis caused by the two classes of drugs, was independent of Ca2+ influx in the cells. In addition, we show that the action of these drugs on phosphatidylserine synthesis was not mimicked by modifications of membrane potential. The regulation of both K+ channels and the base exchange enzyme system thus occurs through a similar (or common) pathway that is independent of Ca(2+)-influx and membrane potential.lld:pubmed
pubmed-article:8454049pubmed:languageenglld:pubmed
pubmed-article:8454049pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:citationSubsetIMlld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8454049pubmed:statusMEDLINElld:pubmed
pubmed-article:8454049pubmed:monthMarlld:pubmed
pubmed-article:8454049pubmed:issn0014-5793lld:pubmed
pubmed-article:8454049pubmed:authorpubmed-author:AusselCClld:pubmed
pubmed-article:8454049pubmed:authorpubmed-author:BreittmayerJ...lld:pubmed
pubmed-article:8454049pubmed:issnTypePrintlld:pubmed
pubmed-article:8454049pubmed:day15lld:pubmed
pubmed-article:8454049pubmed:volume319lld:pubmed
pubmed-article:8454049pubmed:ownerNLMlld:pubmed
pubmed-article:8454049pubmed:authorsCompleteYlld:pubmed
pubmed-article:8454049pubmed:pagination155-8lld:pubmed
pubmed-article:8454049pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:meshHeadingpubmed-meshheading:8454049-...lld:pubmed
pubmed-article:8454049pubmed:year1993lld:pubmed
pubmed-article:8454049pubmed:articleTitleImidazole antimycotics inhibitors of cytochrome P450 increase phosphatidylserine synthesis similarly to K(+)-channel blockers in Jurkat T cells.lld:pubmed
pubmed-article:8454049pubmed:affiliationINSERM U343, Interactions cellulaires en Immunologie, Faculté de Médecine, Nice, France.lld:pubmed
pubmed-article:8454049pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8454049pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8454049lld:pubmed